Publication | Open Access
Phase II/III blood first assay screening trial (BFAST) in patients (pts) with treatment-naïve NSCLC: Initial results from the ALK+ cohort
33
Citations
0
References
2019
Year
Treatment-naïve NsclcOncologyClinical EndpointAlk+ CohortClinical EvidenceClinical TrialsPhase Ii/iii BloodPharmacotherapyDrug TrialMedicineRadiologyHealth Sciences
No additional data available for this publication yet. Check back later!